These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 33428502)
21. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda. Howard N; Walls H; Bell S; Mounier-Jack S Vaccine; 2018 Sep; 36(37):5536-5543. PubMed ID: 30076103 [TBL] [Abstract][Full Text] [Related]
22. Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies. Vodicka E; Zimmermann M; Lopez AL; Silva MW; Gorgolon L; Kohei T; Mooney J; Muhib F; Pecenka C; Marfin AA Vaccine; 2020 Mar; 38(13):2833-2840. PubMed ID: 32085954 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account. Suwantika AA; Tu HA; Postma MJ Vaccine; 2013 Jul; 31(32):3300-7. PubMed ID: 23707163 [TBL] [Abstract][Full Text] [Related]
24. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723 [TBL] [Abstract][Full Text] [Related]
25. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines. Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163 [TBL] [Abstract][Full Text] [Related]
27. Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making? Pan XF; Griffiths UK; Pennington M; Yu H; Jit M Vaccine; 2015 Nov; 33(46):6164-72. PubMed ID: 26435189 [TBL] [Abstract][Full Text] [Related]
28. Planning and priority setting for vaccine development and immunization. Phelps CE; Madhavan G; Gellin B Vaccine; 2017 Jan; 35 Suppl 1():A50-A56. PubMed ID: 28017444 [TBL] [Abstract][Full Text] [Related]
30. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020. Donadel M; Panero MS; Ametewee L; Shefer AM Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592 [TBL] [Abstract][Full Text] [Related]
31. Setting priorities for new vaccination programs by using public health officers and immunization managers opinions. Gilca V; Sauvageau C; McNeil S; Gemmill IM; Dionne M; Dobson S; Ouakki M; Lavoie F; Duval B Vaccine; 2008 Aug; 26(33):4204-9. PubMed ID: 18582998 [TBL] [Abstract][Full Text] [Related]
32. Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction. Muhib FB; Pecenka CJ; Marfin AA Clin Infect Dis; 2020 Jul; 71(Suppl 2):S165-S171. PubMed ID: 32725237 [TBL] [Abstract][Full Text] [Related]
33. Bridging the gap: need for a data repository to support vaccine prioritization efforts. Madhavan G; Phelps C; Sangha K; Levin S; Rappuoli R Vaccine; 2015 Jun; 33 Suppl 2(0 2):B34-9. PubMed ID: 26022565 [TBL] [Abstract][Full Text] [Related]
34. Discrepancies between multicriteria decision analysis-based ranking and intuitive ranking for pharmaceutical benefit-risk profiles in a hypothetical setting. Hoshikawa K; Ono S J Clin Pharm Ther; 2017 Feb; 42(1):80-86. PubMed ID: 27914099 [TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ; Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149 [TBL] [Abstract][Full Text] [Related]
37. Emerging issues in vaccine economics: perspectives from the USA. Lieu TA; Thompson KM; Prosser LA; O'Brien MA; Yusuf HR; Shefer AM; Weinstein MC; Rickert DL Expert Rev Vaccines; 2002 Dec; 1(4):433-42. PubMed ID: 12901581 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of hepatitis A vaccination in Indonesia. Suwantika AA; Beutels P; Postma MJ Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941 [TBL] [Abstract][Full Text] [Related]